Cite
Neural symptoms in a gene knockout mouse model of Sjögren-Larsson syndrome are associated with a decrease in 2-hydroxygalactosylceramide.
MLA
Kanetake, Tsukasa, et al. “Neural Symptoms in a Gene Knockout Mouse Model of Sjögren-Larsson Syndrome Are Associated with a Decrease in 2-Hydroxygalactosylceramide.” FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology, vol. 33, no. 1, Jan. 2019, pp. 928–41. EBSCOhost, https://doi.org/10.1096/fj.201800291R.
APA
Kanetake, T., Sassa, T., Nojiri, K., Sawai, M., Hattori, S., Miyakawa, T., Kitamura, T., & Kihara, A. (2019). Neural symptoms in a gene knockout mouse model of Sjögren-Larsson syndrome are associated with a decrease in 2-hydroxygalactosylceramide. FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology, 33(1), 928–941. https://doi.org/10.1096/fj.201800291R
Chicago
Kanetake, Tsukasa, Takayuki Sassa, Koki Nojiri, Megumi Sawai, Satoko Hattori, Tsuyoshi Miyakawa, Takuya Kitamura, and Akio Kihara. 2019. “Neural Symptoms in a Gene Knockout Mouse Model of Sjögren-Larsson Syndrome Are Associated with a Decrease in 2-Hydroxygalactosylceramide.” FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology 33 (1): 928–41. doi:10.1096/fj.201800291R.